Novo Nordisk Market Cap 2006-2019 | NVO
Novo Nordisk market cap history and chart from 2006 to 2019. Market capitalization (or market value) is the most commonly used method of measuring the size of a publicly traded company and is calculated by multiplying the current stock price by the number of shares outstanding. Novo Nordisk market cap as of March 27, 2020 is $134.41B.
||Large Cap Pharmaceutical
Novo Nordisk is a world leader in insulin and diabetes care and also manufactures and markets a variety of other pharmaceutical products. Furthermore the company is the world's largest producer of industrial enzyme products. The company believes that everyone must care for the environment and our natural resources.